Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- befree-20150227 importedOn "2015-02-27" NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion wasGeneratedBy ECO_0000203 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion wasDerivedFrom befree-20150227 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion SIO_000772 11714450 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion evidence source_evidence_literature NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion description "[Paclitaxel and SN-38 (an active metabolite of irinotecan (CPT-11)) are two drugs that are effective in patients with DDP-resistant ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.